According to Medical News Today, a new study paired turmeric with the anti-nausea drug thalidomide. Together, the two products were able to create “hybrid molecules” to kill multiple myeloma cancer cells.
“Although thalidomide disturbs the microenvironment of tumor cells in bone marrow, it disintegrates in the body. Curcumin, also active against cancers, is limited by its poor water solubility. But the combination of thalidomide and curcumin in the hybrid molecules enhances both the cytotoxicity and solubility,” says the study’s author Shijun Zhang, of the Department of Medicinal Chemistry at the VCU School of Pharmacy.
This is good news, right? Multiple myeloma is the cancer of plasma cells. It’s relatively uncommon and has a survival rate of about 45% 5-years after diagnosis. Finding a solution for this cancer would be ideal, of course. But the new study may not be “all good”.